Now Available:
Download the podcast of Dr. Cohen's video presentation

CME Opportunity:

International Society of Extremity MRI in Rheumatology Conference:
Chicago, April 10, 2008

Musculoskeletal Report provides cutting-edge scientific updates through in-depth interviews, on-location coverage of medical meetings, expert-led panel discussions, and live newscasts. With biweekly and special edition newsletters, MSK Report is the top online resource for staying abreast of the most current and clinically relevant information in the field of musculoskeletal disease and treatment.

MSK Video Report:
New Treatment Developments
Dr. Marc Cohen presents new drugs and treatment options for RA in the final installment of our 4-part series, "RA and Infusion Therapy"...

Arthritis: Arthritis Patients Who Mix Prescription Drugs, OTC NSAIDs Report Lower Quality of Life
Mixing over-the-counter and prescription nonsteroidal anti-inflammatory drugs (NSAIDs) may be putting some arthritis patients at risk, or may be a sign that current treatment is inadequate...

Autoimmunity: ADHD Drugs Linked to Raynaud's Syndrome in Children
CNS stimulants used to treat ADHD have been linked to development of Raynaud's syndrome in children...

Bones: New Guide Helps Predict 10-Year Fracture Risk
A new guide can help doctors evaluate fracture risk and make treatment decisions in patients with osteopenia and osteoporosis...

BioPharm Business: Abbott Receives FDA Approval for Humira (Adalimumab) for Polyarticular Juvenile Idiopathic Arthritis; EOW Dosing
Abbott Laboratories announced it has received US FDA approval to market Humira (adalimumab) as a treatment to reduce signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis...

BioPharm Business: EUSA Out-Licenses Preclinical Stage Human Anti-IL-6 Antibody to GSK for up to $44 Million Plus Royalties
EUSA Pharma Inc announced that it has out-licensed the exclusive worldwide rights to its preclinical-stage human anti-interleukin (IL)-6 antibody (OP-R003) to GlaxoSmithKline (GSK)...

To remove your e-mail address from our mailing list, please reply to this e-mail with "unsubscribe" in the subject line. For questions and comments regarding this newsletter please contact .